Bruce C. Conway
Director/Board Member bei Trigemina, Inc.
Aktive Positionen von Bruce C. Conway
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Trigemina, Inc.
 Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Director/Board Member | - | - |
Karriereverlauf von Bruce C. Conway
Ehemalige bekannte Positionen von Bruce C. Conway
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CLEARPOINT NEURO, INC. | Director/Board Member | 01.05.2011 | 12.04.2013 |
| Independent Dir/Board Member | 01.05.2011 | 12.04.2013 | |
Whitehall Corp.
 Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Director/Board Member | - | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
Sektoral
| Health Technology | 3 |
| Electronic Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CLEARPOINT NEURO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Whitehall Corp.
Whitehall Corp. Aerospace & DefenseElectronic Technology Part of Waste Connections, Inc., Whitehall Corp. is a private company that makes and sells marine sensing systems. The company is based in Dallas, TX. Whitehall was acquired by Aviation Sales Co. on July 31, 1998 for $103.27 million. | Electronic Technology |
Trigemina, Inc.
Trigemina, Inc. Pharmaceuticals: MajorHealth Technology Trigemina, Inc. develops drugs to control pain and migraine headache. Its platform is based on proprietary formulations of oxytocin, a naturally-occurring hormone, delivered through nasal-cerebral pathways for the treatment of a large spectrum of chronic and acute neurological disorders. The company was founded by David C. Yeomans in 2006 and is headquartered in Moraga, CA. | Health Technology |
- Börse
- Insiders
- Bruce C. Conway
- Erfahrung
